Evidence map›Paper›PMID 22689379›Full record

ArticleHepatology (Baltimore, Md.)2012

Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.

Jyoti Srivastava, Ayesha Siddiq, Luni Emdad, Prasanna Kumar Santhekadur, Dong Chen, Rachel Gredler, Xue-Ning Shen, Chadia L Robertson, Catherine I Dumur, Phillip B Hylemon and 10 more

Abstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jyoti SrivastavaDepartment of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA.
Ayesha Siddiq
Luni Emdad
Prasanna Kumar Santhekadur
Dong Chen
Rachel Gredler
Xue-Ning Shen
Chadia L Robertson
Catherine I Dumur
Phillip B Hylemon
Nitai D Mukhopadhyay
Deepak Bhere
Khalid Shah
Rushdy Ahmad
Shah Giashuddin
Jillian Stafflinger
Mark A Subler
Jolene J Windle
Paul B Fisher
Devanand Sarkar

Funding

Analysis of a novel regulator of hepatocellular carcinomaR01CA138540 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SARKAR, DEVANAND · 2010 to 2014
$1.6M
AEG-1: Novel Gene Involved in Malignant GliomaR01CA134721 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FISHER, PAUL B · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA134721NCI NIH HHS R01 CA138540
6 · The paper itself

Abstract

unlabelledAstrocyte elevated gene-1 (AEG-1) is a key contributor to hepatocellular carcinoma (HCC) development and progression. To enhance our understanding of the role of AEG-1 in hepatocarcinogenesis, a transgenic mouse with hepatocyte-specific expression of AEG-1 (Alb/AEG1) was developed. Treating Alb/AEG-1, but not wild-type (WT) mice, with N-nitrosodiethylamine resulted in multinodular HCC with steatotic features and associated modulation of expression of genes regulating invasion, metastasis, angiogenesis, and fatty acid synthesis. Hepatocytes isolated from Alb/AEG-1 mice displayed profound resistance to chemotherapeutics and growth factor deprivation with activation of prosurvival signaling pathways. Alb/AEG-1 hepatocytes also exhibited marked resistance toward senescence, which correlated with abrogation of activation of a DNA damage response. Conditioned media from Alb/AEG-1 hepatocytes induced marked angiogenesis with elevation in several coagulation factors. Among these factors, AEG-1 facilitated the association of factor XII (FXII) messenger RNA with polysomes, resulting in increased translation. Short interfering RNA-mediated knockdown of FXII resulted in profound inhibition of AEG-1-induced angiogenesis.

conclusionWe uncovered novel aspects of AEG-1 functions, including induction of steatosis, inhibition of senescence, and activation of the coagulation pathway to augment aggressive hepatocarcinogenesis. The Alb/AEG-1 mouse provides an appropriate model to scrutinize the molecular mechanism of hepatocarcinogenesis and to evaluate the efficacy of novel therapeutic strategies targeting HCC.

Indexed as

Disease Models, AnimalAnimalsAntineoplastic AgentsCarcinoma, HepatocellularCell Adhesion MoleculesCells, CulturedCell Transformation, NeoplasticCellular SenescenceDiethylnitrosamineDoxorubicinDrug Resistance, NeoplasmFactor XIIFatty AcidsFatty LiverFluorouracilGene Expression ProfilingAntineoplastic AgentsCell Adhesion MoleculesDiethylnitrosamineDoxorubicinFactor XIIFatty AcidsFluorouracilMembrane ProteinsMTDH protein, humanRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID22689379
PMCPMC3449036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.